Blood Product Replacement for Postpartum Hemorrhage
Authors:
- Andrea J. FullerAFAndrea J. Fuller
- Brenda A. BucklinBBBrenda A. Bucklin
- 1 March 2010
- journal article
- review article
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 53 (1) , 196-208
Abstract
Hemorrhage requiring blood transfusion is a common occurrence in obstetrics. This article reviews each step in the transfusion process, including laboratory preparation of blood, indications for various blood components, complications of blood transfusion, massive transfusion, and alternatives to homologous blood. Current thinking regarding transfusion-related acute lung injury, transfusion-related immunomodulation, early use of plasma for massive transfusion, and the use of adjuvant agents such as activated recombinant factor VII are also discussed.Keywords
This publication has 35 references indexed in Scilit:
- Transfusion Management of Trauma PatientsAnesthesia & Analgesia, 2009
- Transfusion-transmitted infectious diseasesBiologicals, 2009
- The Accuracy of Blood Loss Estimation After Simulated Vaginal DeliveryAnesthesia & Analgesia, 2007
- Use of recombinant activated factor VII for massive postpartum hemorrhageActa Obstetricia et Gynecologica Scandinavica, 2007
- How we treat: management of life‐threatening primary postpartum hemorrhage with a standardized massive transfusion protocolTransfusion, 2007
- Evidence-Based Platelet Transfusion GuidelinesHematology-American Society Hematology Education Program, 2007
- The Best Years of My LifeAnesthesiology, 2007
- ACOG Practice Bulletin No. 76: Postpartum HemorrhageObstetrics & Gynecology, 2006
- Autologous blood transfusion in patients with placenta previaActa Obstetricia et Gynecologica Scandinavica, 2005
- Autologous blood transfusion in patients with placenta previaActa Obstetricia et Gynecologica Scandinavica, 2005